https://www.youtube.com/watch?v=Nd823rHUDzgMarkD wrote: ↑Fri Feb 03, 2023 3:05 pm Along with Moderna (MRNA) having already developed a shot to reverse Miocarditis we have this
https://www.wbbjtv.com/2023/02/02/blood ... procedure/
Scientists not backing Covid jabs for 12 to 15-year-olds
The UK's vaccine advisory body has refused to give the green light to vaccinating healthy children aged 12-15 years on health grounds alone.
The JCVI said children were at such a low risk from the virus that jabs would offer only a marginal benefit.
The UK's four chief medical officers have now been asked to have the final say, and to consider the wider impact on schools and society.
Health Secretary Sajid Javid said a decision would be made shortly.
The Joint Committee on Vaccination and Immunisation did advise widening the existing vaccine programme to include an extra 200,000 teenagers with specific underlying conditions.
Doctors identified that children with chronic heart, lung and liver conditions were at much higher risk of Covid than healthy children.
https://www.bbc.com/news/health-58438669
Concerns over integrity of mRNA molecules in some covid-19 vaccines
Documents leaked from the European Medicines Agency (EMA) following a cyber attack in December show that some early commercial batches of Pfizer-BioNTech’s covid-19 vaccine had lower than expected levels of intact mRNA molecules.
These molecules instruct our cells to make a harmless piece of coronavirus protein, triggering an immune response and protecting us from infection if the real virus enters our bodies.
The complete, intact mRNA molecule is essential to the potency of the vaccine.
But in a special report for The BMJ today, journalist Serena Tinari shows that the EMA was concerned about the difference in quality between clinical batches and proposed commercial batches of Pfizer-BioNTech vaccine.
Specifically, EMA had major concerns over unexpectedly low quantities (around 55%) of intact mRNA in batches of the vaccine developed for commercial production.
It is an issue relevant not just to Pfizer-BioNTech’s vaccine but also to those produced by Moderna, CureVac, and others, as well as a “second generation” mRNA vaccine being pursued by Imperial College London.
In an email dated 23 November, a high ranking EMA official outlined a raft of issues. In short, commercial manufacturing was not producing vaccines to the specifications expected, and regulators were unsure of the implications on safety and efficacy.
EMA responded by filing two “major objections” with Pfizer, along with a host of other questions it wanted addressed.
Ultimately, on 21 December, EMA authorised Pfizer-BioNTech’s vaccine and a report published on its website, noted, “the quality of this medicinal product, submitted in the emergency context of the current (covid-19) pandemic, is considered to be sufficiently consistent and acceptable.”
However, it’s unclear how the agency’s concerns were satisfied, writes Tinari.
The BMJ asked Pfizer, Moderna, and CureVac, as well as several regulators, what percentage mRNA integrity they consider acceptable for vaccines against covid-19.
None offered any specifics, and in subsequent correspondence, EMA, US Food and Drug Administration (FDA), and Canadian medicines regulator Health Canada all stated that specific information related to the acceptability criteria is confidential.
https://www.bmj.com/company/newsroom/co ... -vaccines/